Comorbidities are common across all cancers but are more prevalent in certain patient populations. Further research to understand the implications of comorbidities in cancer management is needed.
No takes yet. Share an insight, caveat, or question.
Abravan et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: